Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

Adrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, Kenneth Baker, Sameer Bahal, Helen Baxendale, William Bermingham, Malini Bhole, Evon Boules, Philip Bright, Charu Chopra, Lucy Cliffe, Betsy Cleave, John Dempster, Lisa Devlin, Fatima Dhalla, Lavanya Diwakar, Elizabeth Drewe, Christopher Duncan, Magdalena DziadzioSuzanne Elcombe, Shuayb Elkhalifa, Andrew Gennery, Harichandrana Ghanta, Sarah Goddard, Sofia Grigoriadou, Scott Hackett, Grant Hayman, Richard Herriot, Archana Herwadkar, Aarnoud Huissoon, Rashmi Jain, Stephen Jolles, Sarah Johnston, Sujoy Khan, James Laffan, Peter Lane, Lucy Leeman, David M Lowe, Shanti Mahabir, Dylan James Mac Lochlainn, Elizabeth McDermott, Siraj Misbah, Fiona Moghaddas, Hadeil Morsi, Sai Murng, Sadia Noorani, Rachael O'Brien, Smita Patel, Arthur Price, Tasneem Rahman, Suranjith Seneviratne, Anna Shrimpton, Catherine Stroud, Moira Thomas, Katie Townsend, Prashantha Vaitla, Nisha Verma, Anthony Williams, Siobhan O Burns*, Sinisa Savic*, Alex G Richter*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

17 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology